NEW YORK, Feb 22 - Celera’s Chinese subsidiary Shanghai GeneCore Biotechnologies and Macrogen of South Korea have penned an agreement to jointly develop a SNP database, The Korea Times said Wednesday.

Macrogen, which offers custom sequencing services and has developed DNA chips as well as a set of customized transgenic mice, is currently exploring SNP patterns in the Korean population as part of its effort to branch into personalized medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.